P-GLYCOPROTEIN - LOW CONSTITUTIONAL EXPRESSION DOES NOT CORRELATE WITH TREATMENT FAILURE IN FOLLICULAR LYMPHOMAS

  • Authors:
    • L SEYMOUR
    • M DAVIDGE-PITTS
    • D LEWIS
    • WR BEZWODA
  • View Affiliations

  • Published online on: June 1, 1993     https://doi.org/10.3892/ijo.2.6.1067
  • Pages: 1067-1070
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Tissue P-glycoprotein immunostaining was performed in seventy one patients with follicular large, mixed, or small cell non-Hodgkin's lymphomas. Only six patients (8.5%) demonstrated positive immunostaining for P-glycoprotein. All patients had complete and durable responses to initial therapy. P-glycoprotein (MDR) fails to predict for primary drug resistance in follicular lymphomas and is constitutionally expressed in only a few follicular lymphomas at present.

Related Articles

Journal Cover

June 1993
Volume 2 Issue 6

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
SEYMOUR L, DAVIDGE-PITTS M, LEWIS D and BEZWODA W: P-GLYCOPROTEIN - LOW CONSTITUTIONAL EXPRESSION DOES NOT CORRELATE WITH TREATMENT FAILURE IN FOLLICULAR LYMPHOMAS. Int J Oncol 2: 1067-1070, 1993
APA
SEYMOUR, L., DAVIDGE-PITTS, M., LEWIS, D., & BEZWODA, W. (1993). P-GLYCOPROTEIN - LOW CONSTITUTIONAL EXPRESSION DOES NOT CORRELATE WITH TREATMENT FAILURE IN FOLLICULAR LYMPHOMAS. International Journal of Oncology, 2, 1067-1070. https://doi.org/10.3892/ijo.2.6.1067
MLA
SEYMOUR, L., DAVIDGE-PITTS, M., LEWIS, D., BEZWODA, W."P-GLYCOPROTEIN - LOW CONSTITUTIONAL EXPRESSION DOES NOT CORRELATE WITH TREATMENT FAILURE IN FOLLICULAR LYMPHOMAS". International Journal of Oncology 2.6 (1993): 1067-1070.
Chicago
SEYMOUR, L., DAVIDGE-PITTS, M., LEWIS, D., BEZWODA, W."P-GLYCOPROTEIN - LOW CONSTITUTIONAL EXPRESSION DOES NOT CORRELATE WITH TREATMENT FAILURE IN FOLLICULAR LYMPHOMAS". International Journal of Oncology 2, no. 6 (1993): 1067-1070. https://doi.org/10.3892/ijo.2.6.1067